$1.00
+0.03 (+2.64%)
Open$0.99
Previous Close$0.97
Day High$1.03
Day Low$0.96
52W High$2.35
52W Low$0.87
Volume—
Avg Volume1.27M
Market Cap133.44M
P/E Ratio—
EPS$-0.16
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,694.0% upside
Current
$1.00
$1.00
Target
$37.94
$37.94
$25.58
$37.94 avg
$45.71
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 60.16M | 53.18M | 50.95M |
| Net Income | -7,561,680 | -6,775,030 | -7,233,045 |
| Profit Margin | -12.6% | -12.7% | -14.2% |
| EBITDA | -8,587,792 | -7,436,735 | -8,070,839 |
| Free Cash Flow | -10,429,515 | -10,842,286 | -7,296,543 |
| Rev Growth | -4.1% | +12.5% | -5.7% |
| Debt/Equity | 1.23 | 1.43 | 1.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |